1 Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia. mark.davies1@unimelb.edu.au.
2 The Wellcome Trust Sanger Institute, Hinxton, UK. mark.davies1@unimelb.edu.au.
3 School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia. mark.davies1@unimelb.edu.au.
4 Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia. mark.davies1@unimelb.edu.au.
5 Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
6 The Wellcome Trust Sanger Institute, Hinxton, UK.
7 GSK Vaccines Institute for Global Health, Siena, Italy.
8 Doherty Department, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
9 Department of Microbiology, New York University School of Medicine, New York, NY, USA.
10 Menzies School of Health Research, Darwin, Northern Territory, Australia.
11 Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia.
12 Molecular Bacteriology Laboratory, Université Libre de Bruxelles, Brussels, Belgium.
13 Department of Pediatrics, Queen Fabiola Childrens University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
14 Murdoch Childrens Research Institute, Melbourne, Victoria, Australia.
15 Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
16 Victorian Infectious Diseases Reference Laboratory Epidemiology Unit, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
17 School of Medicine, University of St Andrews, St Andrews, UK.
18 Wellcome Trust Research Centre, Kilifi, Kenya.
19 Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
20 School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.
21 Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia.
22 Laboratory of Bacteriology, Epidemiology Laboratory and Disease Control Division, Laboratório Central do Estado do Paraná, Curitiba, Brazil.
23 Department of Medicine, Universidade Positivo, Curitiba, Brazil.
24 Infection and Immunity Program, Biomedicine Discovery Institute and Department of Microbiology, Monash University, Melbourne, Victoria, Australia.
25 Helmholtz Centre for Infection Research, Braunschweig, Germany.
26 Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
27 Telethon Kids Institute, University of Western Australia and Perth Children's Hospital, Perth, Western Australia, Australia.
28 Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
29 Victorian Infectious Disease Service, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
30 Department of Medicine, University of Cambridge, Cambridge, UK.
31 School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia. mark.walker@uq.edu.au.
32 Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia. mark.walker@uq.edu.au.